Bio

Mr. Boylan has 9 years of healthcare investing, M&A, and policy experience. Prior to joining NaviMed Capital, Mr. Boylan led deal origination and execution at Epsilon Health Investors, a growth investment fund that invests on behalf of a number of leading health systems. At Epsilon, Mr. Boylan focused on investments in innovative digital health, tech-enabled services, and medical device companies. He currently serves on the Board of Directors of ClariMed. Mr. Boylan was previously at DW Healthcare Partners, a lower middle market healthcare private equity fund. At DWHP, Mr. Boylan was involved in originating, executing, and monitoring investments that included branded and unbranded medical products, generic pharmaceuticals, and healthcare IT. Previously, Mr. Boylan was a policy advisor in the US Senate, where he focused on Medicare & Medicaid policy and entitlement reform. He began his career as an investment banker in the healthcare group at UBS. Mr. Boylan holds a BS in Economic History from the London School of Economics, where he graduated with First Class Honours.